Analyst Ratings for Intercept Pharmaceuticals (ICPT)
ICPT Rating Summary
ICPT Price Target Summary
- Highest: $40.00 (Needham & Company)
- Lowest: $29.00 (Brean Capital)
- Average: $33.33
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$33.33 (-3%)
Avg. $ Target:
$33.33 (-3%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/12/2012 | Brean Capital | New Coverage | Buy (N/A) |
29.00 (N/A) |
20.00 | 34.36 | 71.8% | Details |
| 11/5/2012 | BMO Capital | New Coverage | Outperform (N/A) |
31.00 (N/A) |
18.75 | 34.36 | 83.25% | Details |
| 11/5/2012 | Needham & Company » Updated 1/4/2013 |
New Coverage | Buy (N/A) |
40.00 (24.00) |
18.75 | 34.36 | 83.25% | Details |
